To provide an integrative perspective on the molecular pathogenesis, epidemiology, classification, diagnosis, and therapeutic strategies in colorectal cancer (CRC), emphasizing the need for personalized approaches.
Key Findings:
Colorectal cancer incidence is rising, particularly among younger populations and in developing nations, with specific statistics to illustrate this trend.
Three major molecular pathways (CIN, MSI, CIMP) significantly influence CRC development and treatment outcomes, with examples of their impact.
Lifestyle factors and genetic predisposition are critical risk factors for CRC, supported by recent studies.
Advancements in non-invasive diagnostics can improve early detection and screening compliance, with examples of successful implementations.
AI and machine learning are transforming precision oncology in CRC, highlighting specific technologies and their applications.
Interpretation:
The review underscores the complexity of colorectal cancer development and the critical need for integrating molecular profiling with personalized treatment strategies to enhance clinical outcomes.
Limitations:
The review may not cover all emerging research and developments in CRC, particularly recent studies published after the review's completion.
Potential biases in the studies reviewed could affect the conclusions drawn, necessitating a cautious interpretation of the findings.
Conclusion:
Precision oncology approaches that incorporate molecular profiling and patient stratification are essential for enhancing healthcare delivery and outcomes in colorectal cancer, emphasizing the need for ongoing research.
